Anna R. Moverley

854 total citations · 1 hit paper
15 papers, 608 citations indexed

About

Anna R. Moverley is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Anna R. Moverley has authored 15 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 11 papers in Hematology and 7 papers in Immunology. Recurrent topics in Anna R. Moverley's work include Spondyloarthritis Studies and Treatments (13 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Anna R. Moverley is often cited by papers focused on Spondyloarthritis Studies and Treatments (13 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Anna R. Moverley collaborates with scholars based in United Kingdom, Canada and United States. Anna R. Moverley's co-authors include Philip Helliwell, Laura C. Coates, Paul Emery, Philip G. Conaghan, Lucy McParland, Nuria Navarro-Coy, David Meads, Sarah Brown, John O’Dwyer and Karen Vinall‐Collier and has published in prestigious journals such as The Lancet, British Journal of Dermatology and Lara D. Veeken.

In The Last Decade

Anna R. Moverley

14 papers receiving 598 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

2015 329 citations Laura C. Coates, Anna R. Moverley et al. The Lancet profile →

Peers

Anna R. Moverley

RHEUM

IMMUN

HEMAT

DERMA

Maxime Dougados France

Cristina Fernández‐Carballido Spain

Nick Barkham United Kingdom

Juan Carlos Torre Alonso Spain

Tania Gudu Romania

Silvia Scriffignano Italy

J Medich United States

Steffen Jugl Switzerland

MA Radtke Germany

Esther Yi United States

Maxime Dougados France

Anna R. Moverley

390 ×0.7

RHEUM

202 ×0.5

IMMUN

144 ×0.5

HEMAT

11 ×0.4

DERMA

26 ×1.0

Citations per year, relative to Anna R. Moverley Anna R. Moverley (= 1×) peers Maxime Dougados

Countries citing papers authored by Anna R. Moverley

Since Specialization

Citations

This map shows the geographic impact of Anna R. Moverley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna R. Moverley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna R. Moverley more than expected).

Fields of papers citing papers by Anna R. Moverley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna R. Moverley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna R. Moverley. The network helps show where Anna R. Moverley may publish in the future.

Co-authorship network of co-authors of Anna R. Moverley

This figure shows the co-authorship network connecting the top 25 collaborators of Anna R. Moverley. A scholar is included among the top collaborators of Anna R. Moverley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna R. Moverley. Anna R. Moverley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Helliwell, Philip, Laura C. Coates, Anna R. Moverley, et al.. (2019). Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial. The Journal of Rheumatology. 47(9). 1338–1343. 13 indexed citations

O’Dwyer, John, David Meads, Claire Hulme, et al.. (2017). Cost‐Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. Arthritis Care & Research. 70(3). 462–468. 10 indexed citations

Coates, Laura C., L. Savage, Robin Waxman, et al.. (2016). An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas. Clinical Rheumatology. 36(3). 719–723. 1 indexed citations

Moverley, Anna R., Robin Waxman, Maarten de Wit, et al.. (2016). Development of a Flare Instrument for Use in Psoriatic Disease: A Report from the 2015 GRAPPA Annual Meeting. The Journal of Rheumatology. 43(5). 974–978. 13 indexed citations

Rothery, Claire, Laura Bojke, Gerry Richardson, et al.. (2016). A discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis. Clinical Rheumatology. 35(12). 2967–2974. 8 indexed citations

Wit, Maarten de, Willemina Campbell, Laura C. Coates, et al.. (2016). Let’s Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology. 43(5). 970–973. 6 indexed citations

Coates, Laura C., L. Savage, Robin Waxman, et al.. (2016). Comparison of screening questionnaires to identify psoriatic arthritis in a primary-care population: a cross-sectional study. British Journal of Dermatology. 175(3). 542–548. 26 indexed citations

Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2015). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. The Lancet. 386(10012). 2489–2498. 329 indexed citations breakdown →

Moverley, Anna R., Karen Vinall‐Collier, & Philip Helliwell. (2015). It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis. Lara D. Veeken. 54(8). 1448–1453. 33 indexed citations

10.

Moverley, Anna R., Laura C. Coates, Helena Marzo‐Ortega, et al.. (2015). A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)). Clinical Rheumatology. 34(8). 1407–1412. 20 indexed citations

11.

Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2014). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial. The Lancet. 383. S36–S36. 11 indexed citations

12.

Moverley, Anna R., Laura C. Coates, & Philip Helliwell. (2014). Aiming for remission in psoriatic arthritis. International Journal of Clinical Rheumatology. 9(2). 147–153.

13.

Coates, Laura C., Nuria Navarro-Coy, Sarah Brown, et al.. (2013). The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders. 14(1). 101–101. 76 indexed citations

14.

Moverley, Anna R., Laura C. Coates, & Philip Helliwell. (2013). Can biologic therapies be withdrawn or tapered in psoriatic arthritis?. PubMed. 31(4 Suppl 78). S51–3. 3 indexed citations

15.

Freeston, Jane, Laura C. Coates, J. Nam, et al.. (2013). Is There Subclinical Synovitis in Early Psoriatic Arthritis? A Clinical Comparison With Gray‐Scale and Power Doppler Ultrasound. Arthritis Care & Research. 66(3). 432–439. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact